PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30320262-4	2018	Considering that triterpenoids from natural sources have been identified as inhibitors of nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kappaB) signaling, docking studies were conducted to evaluate whether NF-kappaB may be a potential target.	triterpenoids	17-30	nuclear factor kappa B subunit 1	Homo sapiens	153-162	
30320262-4	2018	Considering that triterpenoids from natural sources have been identified as inhibitors of nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kappaB) signaling, docking studies were conducted to evaluate whether NF-kappaB may be a potential target.	triterpenoids	17-30	nuclear factor kappa B subunit 1	Homo sapiens	226-235	
25027934-1	2014	The new series of pentacyclic triterpenoids reduced lantadene A (3), B (4), and 22beta-hydroxy-3-oxo-olean-12-en-28-oic acid (5) analogs were synthesized and tested in vitro for their NF-kappaB and IKKbeta inhibitory potencies and cytotoxicity against A549 lung cancer cells.	triterpenoids	30-43	nuclear factor kappa B subunit 1	Homo sapiens	184-193	
30057155-0	2018	Cytotoxic and NF-kappaB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.	triterpenoids	89-102	nuclear factor kappa B subunit 1	Homo sapiens	14-23	
23717159-0	2013	Oleanane-triterpenoids from Panax stipuleanatus inhibit NF-kappaB.	triterpenoids	9-22	nuclear factor kappa B subunit 1	Homo sapiens	56-65	
19213570-11	2009	Moreover, from immunofluorescence experiments we observed that treatment with these triterpenoids prevents nuclear factor NF-kappaB translocation into the nucleus and thereby the activation of downstream pathways.	triterpenoids	84-97	nuclear factor kappa B subunit 1	Homo sapiens	122-131	
24457265-1	2014	The C-3, C-17 and C-22 congeners of pentacyclic triterpenoids reduced lantadene A (3), B (4) and 22beta-hydroxyoleanolic acid (5) were synthesized and were tested in vitro for their NF-kappaB and IKKbeta inhibitory potencies and cytotoxicity against A549 lung cancer cells.	triterpenoids	48-61	nuclear factor kappa B subunit 1	Homo sapiens	182-191	
22659375-3	2012	Docking results suggested that both the triterpenoids (1 and 2) showed immune modulatory and anti-inflammatory activity due to high binding affinity to human receptors viz., NF-kappaB p52 (-50.549 kcal/mol), tumor necrosis factor (TNF-alpha) (-47.632 kcal/mol), nuclear factor NF-Kappa-B P50 (-16.798 kcal/mol) and cyclooxygenase-2 (-55.244 kcal/mol).	triterpenoids	40-53	nuclear factor kappa B subunit 1	Homo sapiens	277-291	
20392997-0	2010	Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.	triterpenoids	10-23	nuclear factor kappa B subunit 1	Homo sapiens	97-108	
18608528-0	2008	Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.	triterpenoids	39-52	nuclear factor kappa B subunit 1	Homo sapiens	174-183